Efficacy, Safety and Tolerability of Lisdexamfetamine Dimesylate Treatment Compared With Placebo in Adults With Binge‐Eating Disorder: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials
LDX demonstrates significant efficacy in reducing binge-eating behaviours and associated obsessive-compulsive symptoms in patients with BED, with a tolerable safety profile. These findings support the clinical use of LDX for managing BED.
Authors
- Mateus Frizzo Messinger (ORCID: https://orcid.org/0000-0003-1549-3429)
- Maurício Prätzel Ellwanger (ORCID: https://orcid.org/0009-0002-8823-2588)
- Beatriz Westphalen Pomianoski
- V. Astori
- Manuela Pozza Ellwanger
- Daniela Lopes Vieira
Institutions
- Universidade Federal de Minas Gerais (BR)
- Universidade Federal do Rio Grande do Sul (BR)
- Universidade Nove de Julho (BR)
- Escola Superior de Ciências da Santa Casa de Misericórdia de Vitória (BR)
- Universidade do Contestado (BR)
Publication Details
- Journal
- European Eating Disorders Review
- Published
- 2025-12-21
- DOI
- https://doi.org/10.1002/erv.70070
- Primary Topic
- Eating Disorders and Behaviors
- Type
- article
- Field-Weighted Citation Impact
- 0.00